BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 27637923)

  • 1. Fluorescent substrates for ADAM15 useful for assaying and high throughput screening.
    Moss ML; Miller MA; Vujanovic N; Yoneyama T; Rasmussen FH
    Anal Biochem; 2016 Dec; 514():42-47. PubMed ID: 27637923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescent substrates for the proteinases ADAM17, ADAM10, ADAM8, and ADAM12 useful for high-throughput inhibitor screening.
    Moss ML; Rasmussen FH
    Anal Biochem; 2007 Jul; 366(2):144-8. PubMed ID: 17548045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescent substrates useful as high-throughput screening tools for ADAM9.
    Moss ML; Rasmussen FH; Nudelman R; Dempsey PJ; Williams J
    Comb Chem High Throughput Screen; 2010 May; 13(4):358-65. PubMed ID: 20015014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An improved fluorescent substrate for assaying soluble and membrane-associated ADAM family member activities.
    Moss ML; Minond D; Yoneyama T; Hansen HP; Vujanovic N; Rasmussen FH
    Anal Biochem; 2016 Aug; 507():13-7. PubMed ID: 27177841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2, a fluorogenic substrate with increased specificity constants for collagenases and tumor necrosis factor converting enzyme.
    Neumann U; Kubota H; Frei K; Ganu V; Leppert D
    Anal Biochem; 2004 May; 328(2):166-73. PubMed ID: 15113693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the catalytic activity of the membrane-anchored metalloproteinase ADAM15 in cell-based assays.
    Maretzky T; Yang G; Ouerfelli O; Overall CM; Worpenberg S; Hassiepen U; Eder J; Blobel CP
    Biochem J; 2009 Apr; 420(1):105-13. PubMed ID: 19207106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and characterization of a fluorogenic substrate selectively hydrolyzed by stromelysin 1 (matrix metalloproteinase-3).
    Nagase H; Fields CG; Fields GB
    J Biol Chem; 1994 Aug; 269(33):20952-7. PubMed ID: 8063713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of fluorogenic trypsin peptide substrates based on resonance energy transfer.
    Grahn S; Ullmann D; Jakubke H
    Anal Biochem; 1998 Dec; 265(2):225-31. PubMed ID: 9882396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate specificity of cucumisin on synthetic peptides.
    Yonezawa H; Kaizuka H; Uchikoba T; Arima K; Kaneda M
    Biosci Biotechnol Biochem; 2000 Oct; 64(10):2104-8. PubMed ID: 11129582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalytic activity of ADAM8, ADAM15, and MDC-L (ADAM28) on synthetic peptide substrates and in ectodomain cleavage of CD23.
    Fourie AM; Coles F; Moreno V; Karlsson L
    J Biol Chem; 2003 Aug; 278(33):30469-77. PubMed ID: 12777399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the disintegrin metalloproteinase ADAM15 in prostate cancer progression.
    Lucas N; Day ML
    J Cell Biochem; 2009 Apr; 106(6):967-74. PubMed ID: 19229865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolytic Activity Matrix Analysis (PrAMA) for simultaneous determination of multiple protease activities.
    Miller MA; Barkal L; Jeng K; Herrlich A; Moss M; Griffith LG; Lauffenburger DA
    Integr Biol (Camb); 2011 Apr; 3(4):422-38. PubMed ID: 21180771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and characterization of novel fluorogenic substrates of coagulation factor XIII-A.
    Hardes K; Zouhir Hammamy M; Steinmetzer T
    Anal Biochem; 2013 Nov; 442(2):223-30. PubMed ID: 23933241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases.
    Knight CG; Willenbrock F; Murphy G
    FEBS Lett; 1992 Jan; 296(3):263-6. PubMed ID: 1537400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAM15 exerts an antiapoptotic effect on osteoarthritic chondrocytes via up-regulation of the X-linked inhibitor of apoptosis.
    Böhm B; Hess S; Krause K; Schirner A; Ewald W; Aigner T; Burkhardt H
    Arthritis Rheum; 2010 May; 62(5):1372-82. PubMed ID: 20213810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence resonance energy transfer assay for high-throughput screening of ADAMTS1 inhibitors.
    Peng J; Gong L; Si K; Bai X; Du G
    Molecules; 2011 Dec; 16(12):10709-21. PubMed ID: 22186957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence detection of MMP-9. I. MMP-9 selectively cleaves Lys-Gly-Pro-Arg-Ser-Leu-Ser-Gly-Lys peptide.
    Fudala R; Ranjan AP; Mukerjee A; Vishwanatha JK; Gryczynski Z; Borejdo J; Sarkar P; Gryczynski I
    Curr Pharm Biotechnol; 2011 May; 12(5):834-8. PubMed ID: 21446907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel function of human ADAM15 disintegrin-like domain and its derivatives in platelet aggregation.
    Jeon OH; Kim D; Choi YJ; Kim SH; Choi WS; Kim DS
    Thromb Res; 2007; 119(5):609-19. PubMed ID: 16797059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAM 15 is an adhesion receptor for platelet GPIIb-IIIa and induces platelet activation.
    Langer H; May AE; Bültmann A; Gawaz M
    Thromb Haemost; 2005 Sep; 94(3):555-61. PubMed ID: 16268472
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.